Pfizer Vaccines
-
{
- All
- News
-
Government Blocked Pfizer's Covid Vaccine, Claims KCR In New Attack
- Wednesday February 8, 2023
- India News | Asian News International
Telangana Chief Minister K Chandrashekar Rao has alleged that the Central government did everything possible to "forcefully" prevent import of COVID-19 vaccines from Pfizer, especially when people were ready to get the best vaccine.
-
www.ndtv.com
-
China To Distribute Pfizer Vaccine In Beijing As Covid Cases Surge: Report
- Tuesday December 27, 2022
- World News | Asian News International
As Covid cases in China continue to rise, Beijing will soon start distributing Pfizer's Covid-19 drug Paxlovid to the community health centres in forthcoming days, CNN reported citing state media on Monday.
-
www.ndtv.com
-
AstraZeneca Covid Jab Linked To Higher Risk Of Rare Blood Clot, Finds Study
- Thursday October 27, 2022
- World News | Agence France-Presse
AstraZeneca's Covid vaccine has been linked to a 30-percent higher risk of getting a very rare blood clotting condition compared to the Pfizer jab, a large international study said on Thursday.
-
www.ndtv.com
-
Pfizer To Seek US Authorisation For 3rd Covid Shot In Children
- Thursday April 14, 2022
- World News | Agence France-Presse
Pfizer and BioNTech on Thursday announced positive results from a clinical trial on the safety and immune response of a third dose of their Covid vaccine in children aged five through 11, adding they would soon seek regulatory authorization.
-
www.ndtv.com
-
Made In India Covid Vaccines Better Than Pfizer, Moderna, Says Adar Poonawalla: Report
- Wednesday April 13, 2022
- India News | Asian News International
Serum Institute of India (SII) CEO Adar Poonawalla today claimed that "Made in India" COVID-19 vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and Moderna.
-
www.ndtv.com
-
Pfizer Shots, Prior Infection May Protect Better vs Omicron: Scientists
- Thursday December 16, 2021
- World News | Janice Kew and Antony Sguazzin, Bloomberg
A two-dose course of Pfizer Inc. and BioNTech SE's Covid-19 shot as well as a previous infection with the disease may give stronger protection against the omicron variant, scientists from the Africa Health Research Institute in South Africa said.
-
www.ndtv.com
-
In New Pandemic Milestone, US Clears Pfizer Shot For Children Aged 5-11
- Saturday October 30, 2021
- World News | Agence France-Presse
The United States on Friday authorised the Pfizer Covid vaccine for children aged 5 to 11, paving the way for 28 million young Americans to soon get immunized.
-
www.ndtv.com
-
Pfizer Vaccine Highly Effective Against COVID-19 Hospitalisations For 6 Months: Lancet Study
- Tuesday October 5, 2021
- Science | Press Trust of India
Two doses of the Pfizer COVID-19 vaccine are 90 per cent effective against hospitalisation from the disease for all variants, including Delta, for at least six months, according to a study published in The Lancet journal on Tuesday.
-
www.ndtv.com
-
US Committee Challenges Pfizer's Covid Booster Authorisation For High-Risk Adults
- Friday September 24, 2021
- World News | Agence France-Presse
A committee of US health experts on Thursday declined to approve Pfizer booster shots for individuals at high risk of Covid exposure due to their jobs, despite authorization from a different agency just the night before.
-
www.ndtv.com
-
US Panel Recommends Pfizer Covid Boosters For Only Elderly, People At High Risk
- Saturday September 18, 2021
- World News | Agence France-Presse
A panel of leading US medical experts advising the government voted in favor of authorizing boosters of Pfizer's coronavirus vaccine for everyone aged 65 and up, as well as people at high risk of developing severe Covid.
-
www.ndtv.com
-
What 'Very Real Fourth Wave' Caused By Delta Means For US
- Tuesday August 3, 2021
- World News | Robert Langreth, Bloomberg
A surge in Covid-19 cases across the U.S. brought on by the fast-spreading delta variant is increasing pressure on U.S. drug regulators to fully approve Pfizer Inc.'s vaccine, the first one to apply for full licensure in the U.S.
-
www.ndtv.com
-
"Not Even Enough For...": Vaccine Panel Chief On Pfizer, Moderna Offers
- Tuesday August 3, 2021
- India News | Reported by Sreenivasan Jain, Edited by Anindita Sanyal
All US-based vaccine makers are insisting on indemnity and liability clauses and Indias reluctance to meet them is slowing down their entry in the market, NK Arora, head of the governments vaccine panel told NDTV yesterday.
-
www.ndtv.com
-
Pfizer, AstraZeneca Vaccine Antibody Levels May Decline In 2-3 Months: Lancet Study
- Tuesday July 27, 2021
- Science | Press Trust of India
Total antibody levels start to wane six weeks after complete immunisation with Pfizer and AstraZeneca vaccines, and can reduce by more than 50 per cent over 10 weeks, according to study published in The Lancet journal.
-
www.ndtv.com
-
Israel To Provide 1 Million "About To Expire" Pfizer Vaccine Doses To Palestine
- Friday June 18, 2021
- World News | Agence France-Presse
Israel is to provide around one million doses of Covid-19 vaccine to the Palestinian Authority in a swap as their expiry date looms, the Israeli prime minister's office said Friday.
-
www.ndtv.com
-
US To Buy 500 Million Pfizer Vaccine Doses, Donate Jabs Globally: Report
- Thursday June 10, 2021
- World News | Agence France-Presse
The administration of President Joe Biden is buying 500 million doses of the Pfizer-BioNTech Covid-19 vaccine to distribute among other countries, US media reported Wednesday citing people familiar with the matter.
-
www.ndtv.com
-
Government Blocked Pfizer's Covid Vaccine, Claims KCR In New Attack
- Wednesday February 8, 2023
- India News | Asian News International
Telangana Chief Minister K Chandrashekar Rao has alleged that the Central government did everything possible to "forcefully" prevent import of COVID-19 vaccines from Pfizer, especially when people were ready to get the best vaccine.
-
www.ndtv.com
-
China To Distribute Pfizer Vaccine In Beijing As Covid Cases Surge: Report
- Tuesday December 27, 2022
- World News | Asian News International
As Covid cases in China continue to rise, Beijing will soon start distributing Pfizer's Covid-19 drug Paxlovid to the community health centres in forthcoming days, CNN reported citing state media on Monday.
-
www.ndtv.com
-
AstraZeneca Covid Jab Linked To Higher Risk Of Rare Blood Clot, Finds Study
- Thursday October 27, 2022
- World News | Agence France-Presse
AstraZeneca's Covid vaccine has been linked to a 30-percent higher risk of getting a very rare blood clotting condition compared to the Pfizer jab, a large international study said on Thursday.
-
www.ndtv.com
-
Pfizer To Seek US Authorisation For 3rd Covid Shot In Children
- Thursday April 14, 2022
- World News | Agence France-Presse
Pfizer and BioNTech on Thursday announced positive results from a clinical trial on the safety and immune response of a third dose of their Covid vaccine in children aged five through 11, adding they would soon seek regulatory authorization.
-
www.ndtv.com
-
Made In India Covid Vaccines Better Than Pfizer, Moderna, Says Adar Poonawalla: Report
- Wednesday April 13, 2022
- India News | Asian News International
Serum Institute of India (SII) CEO Adar Poonawalla today claimed that "Made in India" COVID-19 vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and Moderna.
-
www.ndtv.com
-
Pfizer Shots, Prior Infection May Protect Better vs Omicron: Scientists
- Thursday December 16, 2021
- World News | Janice Kew and Antony Sguazzin, Bloomberg
A two-dose course of Pfizer Inc. and BioNTech SE's Covid-19 shot as well as a previous infection with the disease may give stronger protection against the omicron variant, scientists from the Africa Health Research Institute in South Africa said.
-
www.ndtv.com
-
In New Pandemic Milestone, US Clears Pfizer Shot For Children Aged 5-11
- Saturday October 30, 2021
- World News | Agence France-Presse
The United States on Friday authorised the Pfizer Covid vaccine for children aged 5 to 11, paving the way for 28 million young Americans to soon get immunized.
-
www.ndtv.com
-
Pfizer Vaccine Highly Effective Against COVID-19 Hospitalisations For 6 Months: Lancet Study
- Tuesday October 5, 2021
- Science | Press Trust of India
Two doses of the Pfizer COVID-19 vaccine are 90 per cent effective against hospitalisation from the disease for all variants, including Delta, for at least six months, according to a study published in The Lancet journal on Tuesday.
-
www.ndtv.com
-
US Committee Challenges Pfizer's Covid Booster Authorisation For High-Risk Adults
- Friday September 24, 2021
- World News | Agence France-Presse
A committee of US health experts on Thursday declined to approve Pfizer booster shots for individuals at high risk of Covid exposure due to their jobs, despite authorization from a different agency just the night before.
-
www.ndtv.com
-
US Panel Recommends Pfizer Covid Boosters For Only Elderly, People At High Risk
- Saturday September 18, 2021
- World News | Agence France-Presse
A panel of leading US medical experts advising the government voted in favor of authorizing boosters of Pfizer's coronavirus vaccine for everyone aged 65 and up, as well as people at high risk of developing severe Covid.
-
www.ndtv.com
-
What 'Very Real Fourth Wave' Caused By Delta Means For US
- Tuesday August 3, 2021
- World News | Robert Langreth, Bloomberg
A surge in Covid-19 cases across the U.S. brought on by the fast-spreading delta variant is increasing pressure on U.S. drug regulators to fully approve Pfizer Inc.'s vaccine, the first one to apply for full licensure in the U.S.
-
www.ndtv.com
-
"Not Even Enough For...": Vaccine Panel Chief On Pfizer, Moderna Offers
- Tuesday August 3, 2021
- India News | Reported by Sreenivasan Jain, Edited by Anindita Sanyal
All US-based vaccine makers are insisting on indemnity and liability clauses and Indias reluctance to meet them is slowing down their entry in the market, NK Arora, head of the governments vaccine panel told NDTV yesterday.
-
www.ndtv.com
-
Pfizer, AstraZeneca Vaccine Antibody Levels May Decline In 2-3 Months: Lancet Study
- Tuesday July 27, 2021
- Science | Press Trust of India
Total antibody levels start to wane six weeks after complete immunisation with Pfizer and AstraZeneca vaccines, and can reduce by more than 50 per cent over 10 weeks, according to study published in The Lancet journal.
-
www.ndtv.com
-
Israel To Provide 1 Million "About To Expire" Pfizer Vaccine Doses To Palestine
- Friday June 18, 2021
- World News | Agence France-Presse
Israel is to provide around one million doses of Covid-19 vaccine to the Palestinian Authority in a swap as their expiry date looms, the Israeli prime minister's office said Friday.
-
www.ndtv.com
-
US To Buy 500 Million Pfizer Vaccine Doses, Donate Jabs Globally: Report
- Thursday June 10, 2021
- World News | Agence France-Presse
The administration of President Joe Biden is buying 500 million doses of the Pfizer-BioNTech Covid-19 vaccine to distribute among other countries, US media reported Wednesday citing people familiar with the matter.
-
www.ndtv.com